Targeting signalling pathways for the treatment of multiple myeloma

Author： Podar Klaus Hideshima Teru Chauhan Dharminder Anderson Kenneth C

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.2, 2005-04, pp. : 359-381

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Signaling Pathways in Multiple Myeloma

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 6, 2006-12 ,pp. : 407-413

Bentham Science Publishers

Access to resources Recommend Favorite

New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 327-340

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma

Current Medicinal Chemistry, Vol. 21, Iss. 27, 2014-09 ,pp. : 3173-3187

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Signalling Pathways in Hepatocellular Carcinoma

Current Pharmaceutical Design, Vol. 23, Iss. 1, 2017-02 ,pp. : 170-175

Bentham Science Publishers

Access to resources Recommend Favorite

Panobinostat for the treatment of multiple myeloma

By Neri Paola Bahlis Nizar J Lonial Sagar

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 733-747

Informa Healthcare

Access to resources Recommend Favorite